Global Digital Health News

Blaize to hit the Bourses with BurTech Acquisition Corp December 27, 2023 Blaize, a global front-runner in purpose-built AI solutions for edge computing, has revealed plans to go public through a definitive agreement with BurTech Acquisition Corp, a publicly traded special purpose acquisition company.

AstraZeneca to Buy China's Gracell Biotech in a $1.2 Bn Deal December 27, 2023 AstraZeneca will also acquire Gracell's cash, cash equivalents and short-term investments of $234.1 million as of September 30, 2023. The deal is expected to close in the first quarter of 2024.

Bristol Myers to Buy Karuna Therapeutics for $14 Bn to Bolster Neuro Portfolio December 27, 2023 This strategic acquisition fits squarely with Briston’s business development priorities of pursuing assets that are strategically aligned, scientifically sound, financially attractive, and have the potential to address areas of significant unmet medical need.

HHS Introduces New AI Transparency Rule for Healthcare Tech Firms December 22, 2023 HHS) has introduced a new rule to safeguard data interoperability and patient access in the healthcare sector.

Samsung Launches Medications Tracking Feature for its Health App December 22, 2023 The newly added feature will allow users to easily keep track of both their prescription and over-the-counter medications and provide important, relevant information and tips about these medications.

Owkin Partners Merck to Develop & Commercialise AI-Powered Diagnostics December 22, 2023 This partnership seeks to develop a pre-screening procedure to improve testing rates for MSI-H in four types of cancer - endometrial, gastric, small intestinal, and biliary. In these cancer types, MSI-H prevalence is low and MSI-H screening is not routinely performed.

Intas Pharma Inks Agreement with mAbxience for Etanercept Biosimilar December 21, 2023 Further, Intas will leverage mAbxience’s strong sales, marketing capabilities and experience in commercialising new biosimilars. While, mAbxience will be responsible for the development, manufacturing, and supply of the Etanercept biosimilar from its state-of-the-art, Good Manufacturing Practices (GMP) approved facilities.

Wisconsin Nonprofits Froedtert Health & ThedaCare Sign $5.5 Bn Merger Deal December 21, 2023 The $5.5 billion deal, initiated with a definitive agreement in September, received regulatory approval, marking a significant development in the healthcare landscape.

Jefferson Health & Lehigh Valley Health Network Sealing  $14 Bn Merger Deal December 20, 2023 The announcement, made on Tuesday, revealed that the two healthcare giants have signed a non-binding letter of intent, marking a pivotal moment in the creation of a leading integrated care delivery system.

Sun Pharma to Acquire 16.7% Stake in Lyndra Therapeutics for $30 Mn December 20, 2023 This strategic investment seeks to support the development of advanced pharmaceutical delivery technologies and get access to the technology for certain molecules and territories. Reportedly, the stake acquisition is expected to be completed by the end of December 2023.

Google Introduces MedLM AI Models for Healthcare to Streamline Clinical Processes December 14, 2023 Positioned as a tool to assist clinicians and researchers in conducting complex studies and streamlining doctor-patient interactions, MedLM signals Google's commitment to carving a niche in the fiercely competitive healthtech landscape.

AstraZeneca Buys Respiratory Vaccine Developer Icosavax in $1.1 Bn Deal December 14, 2023 Icosavax is developing a combination vaccine candidate targeting RSV and human metapneumovirus (hMPV). RSV is a leading cause of pneumonia in toddlers and the elderly, while hMPV causes very similar respiratory tract infections.